New Study of Ketamine in Depression Receives FDA Approval, But Not Medical Marijuana

There has always been a need for intensive clinical research into ketamine’s medical potential, but obtaining approval for such research has always been a problem. For this reason, the FDA’s recent approval of a study into the use of ketamine infusions for depressive disorders has caught the attention of many. It comes after a number […]


Original post here: New Study of Ketamine in Depression Receives FDA Approval, But Not Medical Marijuana

Comments

Popular posts from this blog

The Delaware Senate approves legislation legalizing cannabis

Say hello to the Black CannaConference & Expo: the B2B event for black cannabis

Solvang, CA. Delays the decision on whether to allow recreational pot sales